5 Recruiting Recurrent Acute Myeloid Leukemia Clinical Trials in California
Explore active recurrent acute myeloid leukemia research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Recurrent Acute Myeloid Leukemia Studies in California
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
CPX-351 Plus Enasidenib for Relapsed AML
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 💊 Investigational Drug / Biologic
BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔